Image 1
Glipizide Tablet
Product Images NDC 0591-0460
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Glipizide (NDC 0591-0460). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Actavis Pharma, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Image 2
This is a medication package of Glipizide tablets with NDC number 0591-0460-01. The package contains 100 tablets manufactured by Reony and distributed by Teva. The usual dosage instruction is not available in the text. The medication should be stored below 30°C and kept out of reach of children. There is also a serialization coding area on the package.*
Image 3
This is a description of Glipizide tablets, a medication used to treat type 2 diabetes. It comes in a bottle of 100 tablets, with each tablet containing 10mg of Glipizide. It is important to keep this medication out of reach of children. The usual dosage should be determined by a healthcare professional and instructions for prescribing can be found inside. The medication should be stored below 30°C and is distributed by Teva Pharmaceuticals in the USA. The given code NOC 0592.0461.01 and the numbers 32075899-01 do not provide any significant information.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
